Posaconazole Prophylaxis for CAPA Prevention in Critically-Ill Patients
Conditions:   COVID-19 Respiratory Infection;   Aspergillosis Intervention:   Drug: Posaconazole Sponsors:   Medical University of Graz;   Merck Sharp & Dohme Corp. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 4, 2021 Category: Research Source Type: clinical trials

Pharmacological Evaluation of Antifungal in Chronic Pulmonary Aspergillosis
Conditions:   Chronic Respiratory Disease;   Chronic Pulmonary Aspergillosis Intervention:   Sponsor:   Assistance Publique - Hôpitaux de Paris Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 1, 2021 Category: Research Source Type: clinical trials